Endo International Ordinary Shares reported $287.76M in Stock for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amarin AMRN:US $ 225.77M 42.05M
Ani Pharmaceuticals ANIP:US $ 92.54M 9.39M
Bristol Myers Squibb BMY:US $ 2142M 38M
Eli Lilly And LLY:US $ 3899.4M 6.4M
Endo International Ordinary Shares ENDP:US $ 287.76M 3.93M
Heron Therapeutics HRTX:US $ 61.32M 4.85M
Hikma Pharmaceutical HIK:LN 62.93B 10.96B
JAZZ PHA JAZZ:US $ 861.7M 123.75M
Lannett LCI:US $ 95.16M 0.28M
Novartis NOVN:VX SF 6880M 117M
Pacira Pharmaceuticals PCRX:US $ 100.59M 3.07M
Patterson Companies PDCO:US $ 874.82M 89.21M
Perrigo Ordinary Shares PRGO:US $ 1079.6M 57.2M
Phibro Animal Health PAHC:US $ 259.16M 9.25M
Revance Therapeutics RVNC:US $ 13.6M 2.94M
Supernus Pharmaceuticals SUPN:US $ 84.86M 3.94M
Takeda 4502:JP Y 927511M 74344M
Teva Pharmaceutical TEVA:IT 4.05B 37M
Xeris Pharmaceuticals Inc XERS:US $ 17.89M 1.01M
Zoetis ZTS:US $ 2205M 148M